Sudeep Pharma — 360° view

Sudeep Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹197 crore and net profit of ₹52 crore for the September 2026 quarter.

Sudeep Pharma (NSE: SUDEEPPHRM) closed at ₹1,191.50 on 20 Nov 2026. Its market capitalisation is ₹13,458 crore and it trades at 71.5 times earnings.

Share price
₹1,191.50 (20 Nov 2026)
Market cap
₹13,458 Cr (20 Nov 2026)
P/E
71.46 (20 Nov 2026)
Revenue
₹197 Cr (September 2026 quarter)
Net profit
₹52 Cr (September 2026 quarter)
ROCE
28.2% (FY26)
ROE
25.2% (FY26)
Book value
₹84.8 (FY26)
Dividend yield
0.13% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,378.00 / ₹524.05 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: SUDEEPPHRM

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.